• Welcome to my Observations

    Online observations of public relations, marketing, advertising and social media; the occasional frivolity; and The Rundown show notes. Jump in, the water's fine.

    Please Note: Everything posted on this blog is my personal opinion and does not necessarily represent the views of my employer or its constituents.

  • My Pinterest

  • LinkedIn

    View Luke Armour's profile on LinkedIn
  • Archives

  • Categories

  • The Rundown Podcast Live

    The Rundown

  • RSS Media Bullseye

    • An error has occurred; the feed is probably down. Try again later.
  • Creative Commons

  • The Show Player

  • Pages

  • July 2006
    S M T W T F S
  • Meta

Not Quite the Tylenol Team

This article from the NY Times shows just how much things have changed since the Tylenol incident from the 80s. I don’t have all the facts, but when I read things like this:

A spokesman for Johnson & Johnson, Mark Wolfe, said: “We disagree with the outcome of this trial. We are evaluating our legal options.”

it makes me realize that this isn’t the same team that worked on the crises from yesteryear. Before Crisis PR, before worlds of spin, and flacks doing damage control, Johnson and Johnson relied on their creed to help them weather a horrific tragedy. Now, things seem different, more litigious, less consumer friendly.

Johnson & Johnson’s lawyers contend that Ms. Thompson did not die of a fentanyl overdose and that there was no evidence her patch leaked. They attributed her death to “natural causes,” like heart problems.

I’m interested in seeing how this all pans out. Will this turn out to be a case of a company protecting itself from lawyers, doctors, and ignorant consumers – or – will this turn out to be a rather large blotch on the Johnson and Johnson name?